查詢結果分析
相關文獻
- Content and Transdermal Delivery of Clobetasol 17-Propionate from Commercial Creams and Ointments
- Clotrimazole外用製劑之品質調查
- 基隆山藥塊莖採收後之生化學研究
- 臺灣紅豆杉天然母樹枝葉紫杉醇類含量的變異與選種價值
- 耐火材料之合成與物性測試
- 兩種速測法在果樹葉片葉綠素含量測定之應用
- 共軛亞麻油酸之功能、來源及含量
- The Toughness Behavior of Fiber Reinforced Concrete
- 除草劑對類地毯草葉綠素含量之影響
- 水分含量對鰺魚漿熱凝膠性及魚糕態產品耐煮性之影響
頁籤選單縮合
題 名 | Content and Transdermal Delivery of Clobetasol 17-Propionate from Commercial Creams and Ointments=市售氯貝他索丙酸乳軟膏製劑之含量測定與穿皮速率研究 |
---|---|
作 者 | 蔡瑞真; | 書刊名 | 藥物食品分析 |
卷 期 | 10:1 2002.03[民91.03] |
頁 次 | 頁7-12 |
分類號 | 418.33 |
關鍵詞 | 氯貝他索丙酸; 含量; 穿皮速率; 外用; 半固體; Clobetasol 17-propionate; Content; Transdermal delivery; Topical; Semisolid; |
語 文 | 英文(English) |
中文摘要 | 氯貝他索丙酸(Clobetasol 17-propionate, CP)乳軟膏製劑是外用皮質類固醇中效價最強的藥品,本研究之目的在評估市售11種含0.05% clobetasol 17-propionate的外用製劑(包括 3 種軟膏和 8 種乳膏)的含量及體外穿皮速率。含量測定結果得 3 種軟膏的 CP 含量在標示量的77.5 - 96.1%之間,而 8 種乳膏的含量則在標示量的 84.5-105.6%之間。體外裸鼠皮滲透試驗結果得軟膏的穿皮速率介於 0 . 156 與0.270 μg/cm2/h之間,而乳膏則為0.100-0.521 μg/cm2/h;8 小時總穿透量在軟膏為 1.03 - 1.75 μg/cm2,乳膏則為0.67 - 2.95 μg/cm2;其滯留時間在軟膏為介於 1 . 48 和 1 . 63 小時間,1.53 - 3.19小時間。如與商品名製劑比較,兩種學名軟膏的穿皮速率分別為 Dermovate軟膏的57.7%和83.5%,而學名乳膏的穿皮速率則為 Dermovate乳膏的19.2-94.8%。研究結果顯示市售0.05%CP乳軟膏製劑的穿皮速率差距差大,可能嚴重影響這些製劑的生體可用率和臨床療效。 |
英文摘要 | Semisolid creams and ointments containing 0.05% w/w clobetasol 17-propionate (CP) as active ingredient are categorized as superpotent topical dermatological corticosteroids. The objective of the study was to evaluate the content and transdermal delivery of CP from eleven commercial dosage forms, including three ointments and eight creams. It was found that the CP content of the ointments ranged from 77.5 to 96.1% of the labeled amount, and that of the creams ranged from 84.0 to 105.6%. In vitro transdermal flux of CP through nude mouse skin ranged from 0.156 to 0.270 μg/cm2/h for ointments, and 0.100 to 0.521 μg/cm2/h for creams. Total amount of CP penetrated in 8 h ranged from 1.03 to 1.75 μg for ointments, and 0.67 to 2.95 μg for creams. Lag time to reach steady-state of delivery ranged from 1.48 to 1.63 h for ointments, and 1.53 to 3.19 h for creams. In comparison with the brand name products, transdermal flux of CP from the generic ointments was 57.7% and 83.5% of Dermovate ointment, and that from the generic creams ranged from 19.2 to 94.8% of Dermovate cream. The results demonstrated that commercial 0.05% CP creams and ointments were highly variable in the transdermal delivery of CP, which may influence their bioavailability and clinical efficacy. |
本系統中英文摘要資訊取自各篇刊載內容。